13D Filing: Celgene Corp /de/ and Alliqua Biomedical Inc. (NASDAQ:ALQA)

Page 4 of 7 – SEC Filing

Item 7. Material to Be Filed as Exhibits.

Item 7 is hereby amended and supplemented by adding the following:

Exhibit 8 – Lock-Up
Agreement, dated March 27, 2017, between Celgene Corporation and
H.C. Wainright & Co., LLC

Follow Adynxx Inc. (NASDAQ:ADYX)